1-9 of 9
Noel-Jean Milpied, PhD
Close
Sort by
Journal Articles

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Anna Sureda, Carmen Canals, Sr., Jean-Paul Vernant, Noel-Jean Milpied, PhD, Jürgen Finke, Johan Maertens, Jean-Pierre Jouet, MD, Charles F. Craddock, BM, MRCP, MRCPath, Karl S Peggs, MD, Steven Le Gouill, MD, Norbert Schmitz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 457.
https://doi.org/10.1182/blood.V112.11.457.457
Published: 2008
Journal Articles

Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

Mohamad Mohty, MD, PhD, Myriam Labopin, Noel-Jean Milpied, PhD, Jan J. Cornelissen, MD, PhD, Didier Blaise, MD, Eefke Petersen, MD, Niklas Theorin, MD, Hakan Goker, Gerard Socie, Vanderson Rocha
Journal: Blood
Blood (2008) 112 (11): 345.
https://doi.org/10.1182/blood.V112.11.345.345
Published: 2008
Journal Articles

Evaluation of Pegfilgrastim Efficacy in Peripheral Blood Stem Cell Mobilization of Patients with Lymphoma

Krimo Bouabdallah, Fontanet Bijou, Marie-Sarah Dilhuydy, Anne Banos, Noel-Jean Milpied, PhD
Journal: Blood
Blood (2008) 112 (11): 4129.
https://doi.org/10.1182/blood.V112.11.4129.4129
Published: 2008
Journal Articles

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Anna Schmitt, Reza Tabrizi, MD, Stephane Vigouroux, Mathieu Sauvezie, Carine Foucaud, Krimo Bouabdallah, marie-Sarah Dilhuydy, Arnaud Pigneux, MD, PhD, Thibaut Leguay, didier-Innocent Adiko, Jean-Michel Boiron, MD, PhD, Gerald Marit, Noel-Jean Milpied, PhD
Journal: Blood
Blood (2008) 112 (11): 4310.
https://doi.org/10.1182/blood.V112.11.4310.4310
Published: 2008
Journal Articles

Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD).

Mohamad Mohty, MD, PhD, Marie- Lorraine Balere, Gerard Socie, Noel-Jean Milpied, PhD, Norbert Ifrah, MD, Mathieu Kuentz, MD, Jean-Luc Harousseau, Jean-Paul Vernant, Mauricette Michallet, MD, Agnes Buzyn, Jean-Yves Cahn, Jean-Henri Bourhis, Didier Blaise, MD, Colette Raffoux, Helene Esperou, Ibrahim Yakoub-Agha, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1151.
https://doi.org/10.1182/blood.V112.11.1151.1151
Published: 2008
Journal Articles

Prior Treatment with Chemotherapy Associated to Gemtuzumab Ozogamicin (GO) Does Not Increase the Risk of Veno-Occlusive Disease (VOD) after Allogeneic Stem Cell Transplantation (all-SCT).

Patrice Chevallier, Thomas Prebet, MD, Pascal Turlure, Mathilde Hunault, Stephane Vigouroux, Catherine Faucher, Thierry Guillaume, Francoise Mechinaud, Sameh Ayari, Jacques Delaunay, MD, Noel-Jean Milpied, PhD, Jean-Luc Harousseau, Norbert Ifrah, MD, Didier Blaise, Norbert Vey, MD, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1121.
https://doi.org/10.1182/blood.V112.11.1121.1121
Published: 2008
Journal Articles

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Mohamad Mohty, MD, PhD, Le Quoc-Hung, Franck E Nicolini, MD, PhD, Frederic Garban, MD, Gerard Socie, Michel Attal, MD, Noel- Jean Milpied, PhD, Bruno Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yakoub-Agha, MD, PhD, Jean-Henri Bourhis, Bernard Rio, Eric Deconinck, Marc Renaud, MD, Jean-Luc Harousseau, Didier Blaise, MD, Mauricette Michallet, MD
Journal: Blood
Blood (2008) 112 (11): 2165.
https://doi.org/10.1182/blood.V112.11.2165.2165
Published: 2008
Journal Articles

High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (auto-SCT) Versus CHOP Regimen in Patients with Untreated Aggressive Non-Hodgkin’s Lymphoma: An Update of the GOELAMS 072 Trial with a Median Follow-up of 9.8 Years

Thomas Gastinne, Gandhi Damaj, Thierry Lamy, PhD, Norbert Ifrah, Eric Deconinck, Remy Gressin, MD, Philippe Colombat, MD, PhD, Vincent Delwail, Christian Berthou, Jean François Rossi, Jean Luc Harousseau, Noel-Jean Milpied, PhD
Journal: Blood
Blood (2008) 112 (11): 770.
https://doi.org/10.1182/blood.V112.11.770.770
Published: 2008
Journal Articles

A Multicenter Randomized Comparison of Maintenance Treatment with Androgens in Elderly Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the Goelams-2002 Study.

Arnaud Pigneux, MD, Chantal Himberlin, MD, Mathilde Hunault-Berger, PhD, Francis Witz, MD, Christian Recher, MD, Jean-Luc Harousseau, PhD, Olivier Tournilhac, MD, Chistian Berthou, PhD, Martine Escoffre-Barbe, MD, Denis Guyotat, MD, Nathalie Fegueux, MD, Martine Delain, MD, Bruno Lioure, MD, Frédéric Bauduer, MD, Eric Jourdan, MD, Didier Bouscary, PhD, Laurence Legros, MD, Frédéric Perry, Noel-Jean Milpied, PhD, Marie-Christine Bene, PhD, Norbert Ifrah, PhD, Jean-Jacques Sotto, PhD
Journal: Blood
Blood (2006) 108 (11): 1983.
https://doi.org/10.1182/blood.V108.11.1983.1983
Published: 2006